Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Melinta Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2MELINTA THERAP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    MELINTA THERAP

    ORITAVANCIN DIPHOSPHATE

    arrow
    BioProcess International US West
    Not Confirmed

    MELINTA THERAP

    U.S.A
    arrow
    BioProcess International US West
    Not Confirmed

    Patent Expiration Date : 2030-04-26

    ORITAVANCIN DIPHOSPHATE

    US Patent Number : 9682061

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 214155

    Patent Use Code : U-3101

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2030-04-26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    MELINTA THERAP

    ORITAVANCIN DIPHOSPHATE

    arrow
    BioProcess International US West
    Not Confirmed

    MELINTA THERAP

    U.S.A
    arrow
    BioProcess International US West
    Not Confirmed

    Patent Expiration Date : 2030-04-26

    ORITAVANCIN DIPHOSPHATE

    US Patent Number : 9682061

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 206334

    Patent Use Code : U-1569

    Delist Requested :

    Patent Use Description : TREATMENT OF BACTERIAL...

    Patent Expiration Date : 2030-04-26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.